Design, synthesis and biological evaluation of novel substituted pyrazole-hydrazine hybrids as potent and safe anti-leukemia agents

Key Points

• Novel pyrazole-hydrazine hybrids show potent anti-leukemia activity with minimized toxicity, indicating their therapeutic potential.
• The research identifies specific compounds that demonstrate significant anti-cancer effects in leukemia cells within a short timeframe.
• Analysis of biological evaluation across various assays supports the efficacy and safety of these hybrids as potential anti-leukemia agents.
• These findings highlight the need for further testing of pyrazole-hydrazine hybrids to validate their clinical use in leukemia treatment.